Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-007637
Filing Date
2022-02-07
Accepted
2022-02-07 21:41:18
Documents
1
Period of Report
2022-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6376
  Complete submission text file 0001209191-22-007637.txt   7743
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address
Farquharson Andrew (Reporting) CIK: 0001865699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40672 | Film No.: 22599135